MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Clinical trial NCT02631239 · UNKNOWN

Trial details

NCT number: NCT02631239
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma, Nasal Type

Start date: 2016-03-16
Primary completion: 2021-03-05
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.